ODonnell Kathleen M 4
4 · BIODELIVERY SCIENCES INTERNATIONAL INC · Filed Oct 20, 2004
Insider Transaction Report
Form 4
ODonnell Kathleen M
10% Owner
Transactions
- Purchase
Common Stock
2004-10-19$3.54/sh+2,200$7,788→ 162,400 total(indirect: By Trust) - Purchase
Common Stock
2004-10-20$3.53/sh+300$1,059→ 162,700 total(indirect: By Trust) - Purchase
Common Stock
2004-10-20$3.61/sh+1,700$6,137→ 164,900 total(indirect: By Trust) - Purchase
Common Stock
2004-10-20$3.55/sh+500$1,775→ 163,200 total(indirect: By Trust) - Purchase
Common Stock
2004-10-18$3.52/sh+2,500$8,800→ 159,900 total(indirect: By Trust) - Purchase
Common Stock
2004-10-19$3.45/sh+300$1,035→ 160,200 total(indirect: By Trust)
Holdings
- 294,118(indirect: By HCG)
Series B Convertible Preferred Stock
From: 2006-03-31→ Common Stock (294,118 underlying) - 4,577
Common Stock
- 35,000(indirect: By Trust)
Warrants
Exercise: $6.30From: 2003-06-24Exp: 2007-06-24→ Common Stock (5,000 underlying) - 3,111,580(indirect: See Footnote)
Common Stock
Footnotes (3)
- [F1]Held by the Francis E. O'Donnell Irrevocable Trust #1, of which reporting party is Trustee.
- [F2]Held by the Francis E. O'Donnell Irrevocable Trust #1, of which reporting party is Trustee. The Series B Convertible Preferred Stock is convertible into shares of the Company's common stock on a one for one basis.
- [F3]Not Applicable